Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Methotrexate IP 5 mg Tablet
Therapeutic Category
Immunology, Oncology, Anticancer, Rheumatology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Cafotrex 5 Tablet (Methotrexate IP 5 mg) is a globally recognized anti-metabolite and immunosuppressant essential in both specialized oncology and chronic autoimmune care. Its versatility makes it a perpetually high-demand product in the specialty medicine market.
Mechanism and Impact:Methotrexate works as a folic acid antagonist by inhibiting the enzyme dihydrofolate reductase (DHFR). This action prevents the synthesis of DNA, RNA, and proteins, thereby slowing down the rapid proliferation of two types of cells:
Cancer Cells: Essential for cancer therapy (e.g., ALL maintenance, Choriocarcinoma).
Immune and Skin Cells: Controls the hyperactive cell turnover seen in severe autoimmune conditions (e.g., severe psoriasis and active rheumatoid arthritis).
Key Therapeutic Uses:
Oncology: Crucial for the maintenance phase of ALL and for treating certain solid tumors and lymphomas.
Autoimmune: The standard, low-dose regimen for managing severe, active Rheumatoid Arthritis and refractory Psoriasis.
We offer an exclusive PCD Pharma Franchise opportunity for Cafotrex 5, giving partners a profitable, dual-target entry into both the oncology and specialty autoimmune sectors.
May cause nausea, vomiting, mouth ulcers, fatigue, dizziness, and elevated liver enzymes. Long-term use may lead to bone marrow suppression, liver toxicity, and lung complications. Regular monitoring is essential.
Rheumatoid arthritis and other inflammatory joint disorders Psoriasis (severe, recalcitrant forms) Certain cancers like acute lymphoblastic leukemia (ALL) and non-Hodgkin's lymphoma As part of chemotherapy regimens or in low doses for autoimmune disease management
To be taken only under strict medical supervision. Avoid alcohol to prevent liver toxicity. Contraindicated in pregnancy – may cause birth defects. Routine blood tests required to monitor blood counts, liver, and kidney function. Folic acid supplementation may be advised to reduce side effects.
Store at room temperature (below 25°C) in a cool, dry place, away from light and moisture. Keep out of reach of children. Do not use if the tablet appears damaged or discolored.
Composition : Abiraterone 250 Mg Tablet
Composition : Acebrophylline (100mg) + Acetylcysteine (600mg)
Composition : Acetylcysteine (600mg) effervescent
Composition : Aceclofenac (200mg) + Rabeprazole (20mg) Capsule
Composition : Lactic acid bacillus (100Million spores) + Saccharomyces boulardii (250mg) + Zinc (10mg)
Composition : Glimepiride (1mg) + Metformin (500mg) SR Bilayered Smart Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Methotrexate IP 5 mg Tablet is a disease-modifying antirheumatic drug (DMARD) and antimetabolite used in the management of rheumatoid arthritis, severe psoriasis, certain autoimmune disorders, and some cancers under specialist supervision. It works by reducing abnormal immune system activity and slowing down cell proliferation. It is a strong rheumatology, dermatology, and oncology specialty segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from steady and long-term prescription demand from rheumatologists, dermatologists, and oncologists. Since it is used in chronic therapies, it ensures consistent repeat prescriptions and stable monthly sales.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities in specialty-care formulations including rheumatology, dermatology, and oncology segments with monopoly rights, quality manufacturing standards, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from long-term chronic disease management demand, specialist prescriptions, and continuous therapy cycles, making it a stable and high-value pharmaceutical category when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in specialty-care formulations can contact Cafoli Lifecare to discuss product availability, regulatory requirements, and PCD pharma franchise opportunities in the rheumatology, dermatology, and oncology segments.